You are using software which is blocking our advertisements (adblocker).
As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!
Click here for a guide on disabling your adblocker.
Sign up for our daily Newsletter and stay up to date with all the latest news!
You are receiving this pop-up because this is the first time you are visiting our site. If you keep getting this message, please enable cookies in your browser.
The Oklahoma State Bureau of Narcotics and Dangerous Drugs Control (OBNDD) has issued formal guidance to medical marijuana business registrants following the federal government’s rescheduling of marijuana, advising operators to secure Drug Enforcement Administration (DEA) registration or risk losing their state licenses.
On April 28, 2026, the U.S. Department of Justice issued AG Order No. 6754-2026, officially rescheduling marijuana covered under state medical marijuana programs from Schedule I to Schedule III of the Controlled Substances Act. In a letter dated May 8, 2026, OBNDD Director Donnie Anderson outlined the obligations this change places on state-licensed manufacturers and distributors.
Under the new federal framework, any medical marijuana manufacturer or distributor operating under a state license is now required to obtain a DEA Schedule III registration. OBNDD has made clear that failure to do so could result in administrative sanctions — up to and including revocation of a business’s state registration. The agency noted this brings medical marijuana operators in line with requirements already in place for other Schedule III registrants it oversees.
Businesses have a 60-day window from the Final Order’s April 28 publication in the Federal Register to apply for the appropriate DEA registration. Operators who submit an application within that window are permitted to continue manufacturing, distributing, and dispensing medical marijuana products while their DEA application remains pending. The DEA administrator is required to process applications received during this period within six months.
OBNDD stated it will not pursue administrative action against OBNDD-registered medical marijuana businesses lacking DEA registration until January 1, 2027, giving operators time to come into compliance. However, the agency stressed that businesses that fail to apply within the 60-day period would not receive the same protection, and any manufacturing or distribution without a DEA registration after that point could expose them to sanctions.
The agency emphasized it is unable to provide legal advice on compliance matters and urged registrants with questions about their obligations under federal or state law to consult with an attorney.
Source: Oklahoma State Bureau of Narcotics and Dangerous Drug Control
Frontpage photo: © Kuprevich | Dreamstime
FreshPublishers © 2005-2026 MMJDaily.com